Scarica l'app Stockscreener
306.28
0.68%
-2.09
Dopo l'orario di chiusura:
307.00
0.72
+0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$308.37
Aprire:
$305.95
Volume 24 ore:
2.39M
Relative Volume:
1.38
Capitalizzazione di mercato:
$59.59B
Reddito:
$328.68B
Utile/perdita netta:
$2.55B
Rapporto P/E:
23.50
EPS:
13.0349
Flusso di cassa netto:
$1.56B
1 W Prestazione:
-4.16%
1M Prestazione:
+3.29%
6M Prestazione:
-7.18%
1 anno Prestazione:
+4.30%
Intervallo 1D:
$301.23
$308.33
Intervallo di 1 settimana:
$301.23
$322.96
Portata 52W:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
306.28 | 60.54B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
830.43 | 99.52B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
233.55 | 53.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
89.11 | 9.64B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.426 | 1.25B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
COR|Cencora Inc|Price:311.235|Chg%:+1.345 - TradingKey
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cencora Inc (COR) Cash Flow - TradingKey
Cencora, Inc. (COR) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Cencora, Inc. (COR) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
How Cencora’s Valuation Re‑Rating At Cencora (COR) Has Changed Its Investment Story - simplywall.st
Is Cencora (COR) Still Trading At A Discount As Its P E Rerating Gains Pace? - Yahoo Finance
Cencora, Inc. (COR) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (COR) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (COR) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora Inc (COR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cencora Inc (COR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cencora, Inc. (COR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Cencora (COR) Stock Could Be 39% Below Fair Value - simplywall.st
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
A4EQAC Bond Risk Profile - TradingView
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical - Yahoo Finance
COR|Cencora Inc|Price:310.184|Chg%:+0.294 - TradingKey
Cencora stock holds steady as investors await fresh numbers - AD HOC NEWS
Cencora Inc (COR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cencora, Inc. (0HF3) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (0HF3) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora stock trades steady as specialty distribution scale and recent earnings shape investor view - AD HOC NEWS
COR stock consolidates after strong fiscal 2025 results and guidance update - Ad-hoc-news.de
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model (NYSE:COR) - Seeking Alpha
Cencora earnings preview: What to expect - MSN
ABC5953643 Bond Risk Profile - TradingView
Cencora stock trades steadily as pharmaceuticals distributor highlights rising revenue and earnings - Ad-hoc-news.de
Cencora, Inc. Stock 12‑Month Price Target Raised to $354.58, Implies 17% Upside - TradingView
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora stock trades near record levels as earnings and guidance underpin healthcare distribution gr - Ad-hoc-news.de
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora stock holds firm as revenue and profit trends stay in focus - Ad-hoc-news.de
US3073EBC8 Bond Risk Profile - TradingView
Cencora stock trades near record levels as specialty distribution growth supports earnings - AD HOC NEWS
Steve Collis: Pharmaceutical Distribution Leader and Former Chairman, President, and CEO of Cencora - BBN Times
Cencora stock holds after fiscal 2026 growth update - ad-hoc-news.de
Cencora stock trades steadily as recent earnings highlight solid revenue growth - ad-hoc-news.de
XS3071246378 Bond Risk Profile - TradingView
XS3071246378 Bond Coupon Profile — Rate & Payments - TradingView
ABC6310083 Bond Coupon Profile — Rate & Payments - TradingView
XS3071246378 Bond Profile — Key Metrics - TradingView
Cencora stock trades steadily as specialty distribution growth supports earnings - Ad-hoc-news.de
Fund Update: 235,570 CENCORA (COR) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio - Quiver Quantitative
Cencora Earnings Preview: What to Expect - inkl
A1ZW87 Bond Coupon Profile — Rate & Payments - TradingView
Lobbying Update: $60,000 of CENCORA INC. lobbying was just disclosed - Quiver Quantitative
ABC6310086 Bond Profile — Key Metrics - TradingView
Is Cencora Inc (COR) Overvalued After 3.9% Rally? GF Value Says - GuruFocus
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cencora Inc Azioni (COR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DURCAN DERMOT MARK | Director |
Jun 18 '26 |
Buy |
274.19 |
4,000 |
1,096,760 |
31,767 |
| DURCAN DERMOT MARK | Director |
May 28 '26 |
Buy |
266.26 |
4,000 |
1,065,040 |
27,767 |
| Battaglia Silvana | Executive Vice President |
Mar 11 '26 |
Option Exercise |
0.00 |
8,415 |
0 |
27,239 |
| Campbell Elizabeth S | Executive Vice President |
Mar 11 '26 |
Option Exercise |
0.00 |
12,623 |
0 |
36,548 |
| Cleary James F | Chief Financial Officer |
Mar 11 '26 |
Option Exercise |
0.00 |
12,623 |
0 |
165,766 |
| Mauch Robert P. | President & CEO |
Feb 20 '26 |
Option Exercise |
86.09 |
3,762 |
323,871 |
69,155 |
| Mauch Robert P. | President & CEO |
Feb 20 '26 |
Sale |
358.94 |
3,762 |
1,350,332 |
65,393 |
| Mauch Robert P. | President & CEO |
Feb 18 '26 |
Sale |
359.46 |
1,333 |
479,160 |
65,393 |
0.87%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):